Claes Wahlestedt on Surprise: HDAC Goes Down, Not Up, in Alzheimer’s Disease
COMMENT These [11C]Martinostat PET studies are nicely executed, informative, and potentially useful for future CNS drug-discovery pursuits when studying target engagement, etc. However, they do not help validate/invalidate HDACs as drug targets for AD or any ...